▲ Peaking Business

Replimune’s twice-rejected melanoma drug prevails in FDA adcomm

Name: Trend velocity series: Replimune’s twice-rejected melanoma drug prevails in FDA adcomm
Creator: Newsylist

1sources

1articles

0velocity

+0%since first seen

1h agofirst detected

Coverage (1)

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

▲ Peaking Business

0 sources 0 articles v 0 45m ago

▲ Peaking Business

5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

5 sources 5 articles v 3 45m ago

▲ Peaking Business

1 sources 1 articles v 1 45m ago

▲ Peaking Business

2 sources 2 articles v 4 45m ago

▲ Peaking Business

0 sources 0 articles v 0 1h ago

▲ Peaking Business

4 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

4 sources 5 articles v 3 1h ago